The Analyst Verdict: Corteva In The Eyes Of 11 Experts

Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Corteva (NYSE:CTVA) in the last three months.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	5	5	1	0	0
Last 30D	1	0	0	0	0
1M Ago	1	0	0	0	0
2M Ago	1	3	0	0	0
3M Ago	2	2	1	0	0

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $70.91, with a high estimate of $74.00 and a low estimate of $64.00. This upward trend is evident, with the current average reflecting a 2.92% increase from the previous average price target of $68.90.

Decoding Analyst Ratings: A Detailed Look

The standing of Corteva among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Bill Selesky	Argus Research	Maintains	Buy	$69.00	$69.00
Duffy Fischer	Goldman Sachs	Announces	Buy	$71.00	-
Steve Byrne	B of A Securities	Raises	Buy	$73.00	$69.00
Arun Viswanathan	RBC Capital	Raises	Outperform	$73.00	$72.00
Kristen Owen	Oppenheimer	Raises	Outperform	$72.00	$70.00
Aleksey Yefremov	Keybanc	Raises	Overweight	$70.00	$68.00
Patrick Cunningham	Citigroup	Raises	Buy	$74.00	$69.00
Richard Garchitorena	Wells Fargo	Raises	Overweight	$73.00	$67.00
Benjamin Theurer	Barclays	Raises	Equal-Weight	$64.00	$62.00
Joshua Spector	UBS	Lowers	Buy	$73.00	$74.00
Aleksey Yefremov	Keybanc	Lowers	Overweight	$68.00	$69.00

Key Insights:

• Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Corteva. This insight gives a snapshot of analysts' perspectives on the current state of the company.
• Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Corteva compared to the broader market.
• Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Corteva's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Corteva analyst ratings.

Unveiling the Story Behind Corteva

Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.

A Deep Dive into Corteva's Financials

Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.

Revenue Growth: Corteva's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 7.31%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.

Net Margin: Corteva's net margin is impressive, surpassing industry averages. With a net margin of -1.03%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Corteva's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -0.17%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): Corteva's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.1%, the company showcases efficient use of assets and strong financial health.

Debt Management: Corteva's debt-to-equity ratio is below the industry average. With a ratio of 0.11, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

The Basics of Analyst Ratings

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.